Buprenorphine Hcl And Naloxone Hcl Tablet
Product Images NDC 50268-145

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl And Naloxone Hcl (NDC 50268-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

144 15 2mg

Label for Buprenorphine and Naloxone Sublingual Tablets 2 mg*/0.5 mg*, containing 50 tablets (5 x 10) unit dose. Label states Rx only and includes barcode, storage instructions, and manufacturer information for AvPAK in Pulaski, TN. The label also notes the presence of medication guide and dosage details of buprenorphine 2 mg and naloxone 0.5 mg per tablet.*

FDA Label Image

145 15 8mg 2mg

Label for Buprenorphine and Naloxone Sublingual Tablets, strength 8 mg/2 mg, in a unit dose package of 50 tablets (5 x 10). The label indicates prescription only, includes a barcode, and notes dispensing with a medication guide. Manufactured by AvPAK, Pulaski, TN, the label also provides storage instructions and active ingredient amounts.*

FDA Label Image

561287c0-figure-01 (Buprenorphine And Naloxone Sublingual Tablets 1)

Chemical structure diagram of Buprenorphine HCl, the active ingredient in Buprenorphine HCl and Naloxone HCl sublingual tablets by AvPAK. The structure includes hydroxy, methoxy, and cyclopropyl groups, as well as a hydrochloride salt notation.*

FDA Label Image

561287c0-figure-02 (Buprenorphine And Naloxone Sublingual Tablets 2)

Chemical structure of buprenorphine hydrochloride dihydrate, showing the arrangement of rings, hydroxyl groups, nitrogen atom, and the hydrochloride with two water molecules (dihydrate).*

FDA Label Image

Med Guide Ijmage (Buprenorphine And Naloxone Sublingual Tablets 3)

Illustration showing the sublingual administration of a tablet. A hand is placing a tablet under the tongue inside an open mouth, indicating the correct placement for sublingual absorption.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.